ѻý

<ѻý class="page-title">Endocrinology

Metabolic Syndrome

<ѻý class="page-description">

More in Metabolic Syndrome

Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening

More noteworthy research from the EASD 2024 meeting

Sep 13, 2024
EASD over a photo of IFEMA Convention Center in Madrid, Spain.
Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6

Saxenda group six times more likely to lose at least 5% of BMI

Sep 10, 2024
EASD over a photo of IFEMA Convention Center in Madrid, Spain.
FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin Win

News and commentary from the endocrinology world

Sep 09, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Meat Types and T2D; Semaglutide in Heart Failure; Acromegaly at the Paralympics

News and commentary from the endocrinology world

Sep 03, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
T1D Stem Cell Success Story; Lilly's Discount Tirzepatide Vials; Stelo Now Available

News and commentary from the endocrinology world

Aug 27, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update

News and commentary from the endocrinology world

Aug 20, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Lignins

News and commentary from the endocrinology world

Aug 13, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Eating Disorders After GLP-1s? Tirzepatide for Heart Failure; Soda Taxes and BMI

News and commentary from the endocrinology world

Aug 06, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Faulty FreeStyle Libre 3 Sensors; Endocrine Society Merger; More Levemir Pushback

News and commentary from the endocrinology world

Jul 30, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues

News and commentary from the endocrinology world

Jul 23, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
People Without Diabetes Make Up Growing Share of GLP-1 Users

Approximately one-fourth of new users in 2023 did not have type 2 diabetes

Jul 22, 2024
A photo of a woman holding two injection pens.
Few Stick With Ozempic; Pfizer Making Daily GLP-1; Once-Weekly Insulin Turned Down

News and commentary from the endocrinology world

Jul 16, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
New Investigational Fertility Pill; Biden Wants Lower GLP-1 Prices; BVO to Be Banned

News and commentary from the endocrinology world

Jul 09, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Tirzepatide Bests Semaglutide for Real-World Weight Loss

Injectables were compared at doses approved for type 2 diabetes

Jul 08, 2024
A photo of a box of Mounjaro injection pens.
More in Metabolic Syndrome

1.00 CME Credits
Navigating Cardiovascular Risk: The Critical Role of Lipoprotein(a) Screening and Treatment

0.50 CME Credits
Breakthroughs in Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome Management: Key Findings From ACC 2024

0.50 CME Credits
Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes

1.00 CME Credits
Evidence-Based Strategies and Emerging Approaches for Individualizing Obesity Care

0.25 CME Credits
Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

1.00 CME Credits
Leveraging Continuous Glucose Monitoring (CGM) to Improve Outcomes in Type 2 Diabetes

1.50 CME Credits
Breaking Barriers in Obesity Management: Adopting a Holistic Approach to Optimize Health Outcomes

0.50 CME Credits
Cutting-Edge Treatment Approaches for Patients With T1D and Impaired Awareness of Hypoglycemia (IAH)